STONY BROOK, NY -- (Marketwired) -- 02/03/15

Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, has completed customer feedback demonstrations of its new technology for multi-modal, in-field detection and validation of complementary security elements integrated with its primary SigNature® DNA mark. Platform development now moves from prototype toward customer pilots.

The technology platform is designed to identify APDN DNA-marked products before they are sampled or sent for forensic authentication in one of APDN's laboratories. With a road map to include a mix of chemical, optical, digital and image-processing characteristics, it enables users to identify the presence of a SigNature DNA mark on their product. Some marks can be both encrypted and covert, and require a multi-modal reader just to indicate their presence.

Used either stand-alone or as an element of APDN's digitalDNA® architecture, the multi-modal reader platform has been demonstrated at conferences and customer meetings in combination with commercially available mobile host systems such as laptops and tablets, and data-capture devices such as handheld readers of overt or covert bar codes. The digitalDNA system backbone utilizes proprietary security algorithms operating under a standards-based systems architecture for maximal customer utility.

Targeted applications for the multi-modal reader include print, labeling and packaging; police evidence rooms; parts quality control test labs; the identification of DNA-marked home assets; cash and valuables in transit (CViT); government commodities and identification verification. Customers will realize faster speeds and higher confidence in screening and database-storage of results. 

Judy Murrah, APDN's Chief Information Officer, stated: "Applied DNA Sciences' innovation joins science and information technology to harbor new dimensions of automatic identification for our customers. Our new reader platform -- developed with our partners, Intelligent Product Solutions -- enables APDN-brand marks to increase in complexity and security while being field-screened with simplicity. Follow-on DNA authentication remains our forensic foundation."

"In-field mark detection, validation and authentication are critical to our customers for on-the-spot decision-making about security in their environments. The multi-modal reader is a unique complement to Applied DNA Sciences' world-class forensic science and drives new insights from our digital platform," said Dr. James Hayward, Chairman and CEO, Applied DNA Sciences.

About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Applied DNA Sciences is listed on the NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW. 

Forward-Looking Statement

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

investor contact:
Debbie Bailey
631-240-8817
Email contact

media contact:
Enrique Briz
Dian Griesel Int'l.
212-825-3210
Email contact

program contact:
Judy Murrah
CIO
631-240-8819
Email contact

web:Email contact
twitter: @APDN